Liquidia Corp’s (LQDA) Stock: A -15.64% Simple Moving Average for the Past 20 Days

The stock of Liquidia Corp (LQDA) has gone down by -14.94% for the week, with a -7.86% drop in the past month and a 1.16% rise in the past quarter. The volatility ratio for the week is 3.01%, and the volatility levels for the past 30 days are 6.24% for LQDA. The simple moving average for the past 20 days is -15.64% for LQDA’s stock, with a 9.10% simple moving average for the past 200 days.

Is It Worth Investing in Liquidia Corp (NASDAQ: LQDA) Right Now?

Additionally, the 36-month beta value for LQDA is 0.05. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 1 rating it as “sell.”

The public float for LQDA is 69.01M and currently, short sellers hold a 19.56% ratio of that float. The average trading volume of LQDA on June 10, 2025 was 1.55M shares.

LQDA) stock’s latest price update

Liquidia Corp (NASDAQ: LQDA)’s stock price has plunge by -21.97relation to previous closing price of 18.02. Nevertheless, the company has seen a -14.94% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-02 that MORRISVILLE, N.C., June 02, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that Liquidia is scheduled to make its first commercial shipment of YUTREPIA™ (treprostinil) inhalation powder, marking the first time YUTREPIA will be available to be prescribed to patients at specialty pharmacies. This milestone was achieved only five business days following the U.S. Food and Drug Administration (FDA) approval of YUTREPIA on May 23, 2025, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Analysts’ Opinion of LQDA

Many brokerage firms have already submitted their reports for LQDA stocks, with Oppenheimer repeating the rating for LQDA by listing it as a “Underperform.” The predicted price for LQDA in the upcoming period, according to Oppenheimer is $13 based on the research report published on May 19, 2025 of the current year 2025.

Wells Fargo, on the other hand, stated in their research note that they expect to see LQDA reach a price target of $20. The rating they have provided for LQDA stocks is “Overweight” according to the report published on December 20th, 2024.

LQDA Trading at -6.96% from the 50-Day Moving Average

After a stumble in the market that brought LQDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.56% of loss for the given period.

#####

#####

Insider Trading

Reports are indicating that there were more than several insider trading activities at LQDA starting from Schundler Russell, who sale 8,460 shares at the price of $16.97 back on Jun 04 ’25. After this action, Schundler Russell now owns 582,054 shares of Liquidia Corp, valued at $143,566 using the latest closing price.

Moomaw Scott, the Chief Commercial Officer of Liquidia Corp, sale 6,656 shares at $16.97 during a trade that took place back on Jun 04 ’25, which means that Moomaw Scott is holding 224,921 shares at $112,952 based on the most recent closing price.

Stock Fundamentals for LQDA

Current profitability levels for the company are sitting at:

  • -9.04 for the present operating margin
  • 0.58 for the gross margin

The net margin for Liquidia Corp stands at -9.04. The total capital return value is set at -0.77. Equity return is now at value -188.03, with -60.22 for asset returns.

Based on Liquidia Corp (LQDA), the company’s capital structure generated 0.75 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 2.97. The interest coverage ratio of the stock is -8.74.

Currently, EBITDA for the company is -115.71 million with net debt to EBITDA at 0.2. When we switch over and look at the enterprise to sales, we see a ratio of 84.41. The receivables turnover for the company is 11.34for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.93.

Conclusion

In conclusion, Liquidia Corp (LQDA) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.